Overview

Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
To compare the symptom control rate between 8 weeks esomeprazole treatment regimen group and 2 weeks esomeprazole treatment regimen group in co-diagnosed NERD and chronic gastritis patients, as evaluated by GerdQ after 24 weeks maintenance treatment/follow up.
Phase:
Phase 4
Details
Lead Sponsor:
AstraZeneca
Treatments:
Esomeprazole